Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
08/2000
08/15/2000US6103730 Amine substituted compounds
08/15/2000CA2202280C Sugar modified nucleosides and their use for synthesis of oligonucleotides
08/10/2000WO2000045635A1 Thiazole derivatives and combinatorial libraries thereof
08/09/2000EP1025103A1 Novel polymorphic forms of cipamfylline
08/09/2000CN1262273A Process for preparing guanine by pressing
08/08/2000US6100404 Erythromycin compounds
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/08/2000US6100270 Bicyclic heterocyclic compounds for the treatment of impotence
08/08/2000CA2017066C Azaindenes
08/03/2000WO2000044750A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a)
08/03/2000WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
08/03/2000CA2361518A1 Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
08/02/2000EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules
08/02/2000EP1023292A1 Process for the synthesis of chloropurine intermediates
08/01/2000US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors
07/2000
07/27/2000WO2000043394A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
07/27/2000WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/27/2000WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses
07/27/2000WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
07/26/2000EP1021429A1 Aryl furan derivatives as pde iv inhibitors
07/26/2000EP1021186A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha
07/25/2000US6093819 Reacting guanine with a chlorinating agent in the presence of methyltriethylammonium chloride to form 2-amino-6chloropurine then substituting at 9-position with appropriate side chain, followed by hydrolysis or reduction of 6-chloro moiety
07/25/2000US6093703 Pharmaceutical compositions, containing S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid and 5-formyltetrahydrofolic acid
07/25/2000CA2141029C Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
07/20/2000WO2000041708A1 Composition for treating obesity and aesthetic treatment method
07/20/2000WO2000041474A2 Anti-cd3 immunotoxins and therapeutic uses therefor
07/20/2000WO1999064048A9 Inhibitors of hiv reverse transcriptase
07/20/2000CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor
07/20/2000CA2323711A1 Composition for treating obesity and aesthetic treatment method
07/19/2000EP1019426A1 Novel a 1? adenosine receptor agonists and antagonists
07/19/2000EP1019404A1 Purine acyclonucleosides as antiviral agents
07/19/2000EP1019403A1 Process for preparing purine derivatives
07/19/2000EP1019056A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
07/18/2000US6090937 Methods for producing nucleoside derivatives and intermediates therefor
07/18/2000US6090816 Antiasthma agents
07/12/2000EP1018514A1 NF-$g(k)B INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT
07/12/2000EP1017394A1 Cyclin dependent kinase inhibiting purine derivatives
07/11/2000US6087501 Hydrolysis of imines to form amides
07/11/2000US6087497 Debenzylation of purine to form viricides
07/11/2000CA2012851C Purinyl and pyrimidinyl tetrahydrofurans
07/06/2000WO2000039751A2 System and method for structure-based drug design that includes accurate prediction of binding free energy
07/06/2000WO2000039143A2 Antiviral nucleoside analogues
07/05/2000EP1015451A1 Tetrahydro gamma-carbolines
07/05/2000EP0563168B1 Xanthine derivatives
07/04/2000US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer
07/04/2000US6084082 Solid phase synthesis by attaching beta-lactam having nucleobase to solid support, deprotecting hydroxy group, reacting free hydroxyl group with beta-lactamtide having activated phosphite group, and oxidizing
07/04/2000US6083954 Method of treating cystic fibrosis
07/04/2000US6083953 Treating herpes simplex virus or cytomegalovirus infections; valganciclovir hydrochloride in crystalline form; antiviral; oral administration
07/04/2000US6083483 For the modulation of the motility and peristalsis of the hollow organs of the urogenital and gastrointestinal tract
07/04/2000CA2016142C Sulfonamides
07/04/2000CA1341043C Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
06/2000
06/29/2000WO2000037471A1 2-amino-9-alkylpurines: gaba brain receptor ligands
06/29/2000WO2000023447B1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties
06/28/2000EP1014184A2 Photographic element containing a dir coupler
06/28/2000EP0574386B1 Novel process for the preparation of nucleotides
06/27/2000US6080746 Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections
06/21/2000EP1010700A1 Process for the preparation of guanine under pressure
06/21/2000DE19857949A1 Verfahren zur Herstellung von Guanin unter Druck Process for the preparation of guanine under pressure
06/20/2000CA2013381C Selective adenosine receptor compounds
06/20/2000CA1341034C Heterocyclic 2-alkoxyphenoxysulfonylureas and the use thereof as herbicides or plant growth regulators
06/15/2000WO2000006531A3 Nitric esters and nitrate salts of specific drugs
06/14/2000EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
06/14/2000EP0746326A4 Oligomeric compounds having nitrogen-containing linkages
06/14/2000CN1053435C Method for extracting tea polyphenol and by-products from tea leaves
06/13/2000US6075143 Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids
06/13/2000US6075029 Xanthine modulators of metabolism of cellular P-450
06/13/2000CA2107014C Therapeutic agent for parkinson's disease
06/08/2000WO2000032197A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
06/07/2000EP1006115A2 Imidazopyridines having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
06/07/2000EP1005356A1 Novel antibacterial agents
06/06/2000US6072053 Antiviral compound
06/06/2000US6072051 Viricide against hepatitis b virus with low toxicity
06/06/2000US6071922 Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides
06/02/2000WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
06/02/2000CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors
05/2000
05/31/2000EP1004593A2 Backbone modified oligonucleotide analogues
05/31/2000EP1003746A1 Purine inhibitor of protein kinases, g proteins and polymerases
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/31/2000CN1255132A Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of 1-3-oxaselenolane nucleosides
05/31/2000CN1052984C New erythromycin derivative and its preparing process and application in medicine
05/30/2000US6069250 Method and compositions for the synthesis of dioxolane nucleosides with β-configuration
05/30/2000CA1341007C Alkyl- and alkenylsulfonylureas which are substituted in the heterocycle, processes for their preparation, and their use as herbicides or plant growth regulators
05/25/2000WO2000016755A3 Antiviral combinations of lamivudine and adefovir
05/23/2000US6066641 Phosphodiesterases as molecular targets for anti-asthmatic agents
05/17/2000EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
05/17/2000CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders
05/16/2000US6063569 Methods for automated synthesis of PNA-DNA chimeras and compositions thereof
05/16/2000US6063407 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
05/11/2000WO2000025797A1 Combination therapy to treat hepatitis b virus
05/10/2000EP0999211A1 Novel purine derivatives and medicinal use thereof
05/10/2000EP0998480A1 Nucleotide analog composition and synthesis method
05/10/2000EP0741710B1 Chloropyrimidine intermediates
05/09/2000US6060459 Enhancing blood cell count with oxypurine nucleosides
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/03/2000EP0996617A1 Novel compounds
05/03/2000CN1252071A Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl) phenyl derivatives, their preparation and use in treatment of inflammatory conditions and immune disorders
05/02/2000US6057445 Formation of carbon nitrogen bond, cyclization and halogenation
05/02/2000US6057334 Benzo[g]quinoline derivatives
05/02/2000US6057327 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 120